{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Regulus Therapeutics Inc."},"Symbol":{"label":"Symbol","value":"RGLS"},"Address":{"label":"Address","value":"4224 CAMPUS POINT COURT,SUITE 210, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 202-6300"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes."},"CompanyUrl":{"label":"Company Url","value":"https://www.regulusrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Claire S. Padgett","title":"Senior Vice President-Clinical Operations"},{"name":"Joseph P. Hagan","title":"Chief Executive Officer & Director"},{"name":"Preston S. Klassen","title":"President, Director & Head-Research & Development"},{"name":"Rekha Garg","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}